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The development of the nervous system is critically dependent on the production of functionally diverse neuronal cell types at their
correct locations. In the embryonic neural tube, dorsoventral signaling has emerged as a fundamental mechanism for generating neu-
ronal diversity. In contrast, far less is known about how different neuronal cell types are organized along the rostrocaudal axis. In the
developingmouse and chick neural tube, hindbrain serotonergic neurons and spinal glutamatergic V3 interneurons are produced from
ventral p3 progenitors, which possess a common transcriptional identity but are confined to distinct anterior–posterior territories. In
this study, we show that the expression of the transcription factor Neurogenin3 (Neurog3) in the spinal cord controls the correct
specification of p3-derived neurons. Gain- and loss-of-function manipulations in the chick and mouse embryo show that Neurog3
switches ventral progenitors from a serotonergic to V3 differentiation program by repressing Ascl1 in spinal p3 progenitors through a
mechanism dependent on Hes proteins. In this way, Neurog3 establishes the posterior boundary of the serotonergic system by actively
suppressing serotonergic specification in the spinal cord. These results explain how equivalent p3 progenitors within the hindbrain and
the spinal cord produce functionally distinct neuron cell types.
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Introduction
The hindbrain and spinal cord both display a highly conserved
pattern of dorsoventral gene expression. Fourteen cardinal pop-
ulations of neurons have been identified in the spinal cord on the
basis of their transcription factor profiles, axonal projections, and
neurotransmitter phenotypes (Jessell, 2000; Briscoe andNovitch,
2008; Goulding, 2009). Thirteen of these populations are con-
served in the hindbrain (Gray, 2008). Neurons derived from the
most ventral progenitor domain, termed p3, are an exception to
this rule with serotonergic (5-HT) neurons generated in the
hindbrain and glutamatergic V3 interneurons in the spinal cord
(Briscoe et al., 1999; Zhang et al., 2008; Jacob et al., 2013).
During embryonic development, serotonergic neurons
emerge fromhindbrain p3 progenitors that express the transcrip-
tion factors Nkx2.2, Foxa2, and Ascl1 (Briscoe et al., 1999; Pattyn
et al., 2004; Jacob et al., 2007). 5-HT neuron differentiation re-
quires the orchestrated action of Gata2, Lmx1b, and Pet1 (Hen-
dricks et al., 1999, 2003; Cheng et al., 2003; Ding et al., 2003;
Craven et al., 2004). In the spinal cord, the establishment of p3
identity also requires Nkx2.2, Foxa2, and Ascl1 (Briscoe et al.,
1999; Dessaud et al., 2007; Jacob et al., 2013; this study). How-
ever, instead of producing serotonergic neurons, they produce
glutamatergic V3 interneurons that selectively express the tran-
scription factor Sim1 (Briscoe et al., 1999; Zhang et al., 2008).
Excitatory V3 neurons are components of intraspinal networks
that generate organized motor patterns (Zhang et al., 2008;
Borowska et al., 2013). In contrast, serotonergic neurons inner-
vate large regions of the brain and the spinal cord, where they
modulate a variety of behaviors from anxiety and aggression to
breathing and locomotion (Mu¨ller and Jacobs, 2010; Deneris and
Wyler, 2012).
The exact mechanism that ensures the production of region-
ally restricted serotonergic andV3 fates is still poorly understood.
Recently, Jacob et al. (2013) have shown that reduced expression
of the transcription factor Ascl1 in the spinal cord favors V3
differentiation to the detriment of serotonergic development.
However, the intrinsic mechanisms that repress Ascl1 and ex-
clude 5-HT differentiation from the spinal cord remain to be
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determined. Interestingly, lamprey, fish,
and amphibians contain serotonergic neu-
rons in their ventral spinal cord (Harris-
Warrick et al., 1985; Branchereau et al.,
2000; Lillesaar, 2011), suggesting that the
mechanism that prevents p3 progenitors
from differentiating as serotonergic neu-
ronsmaybe specific to the embryonic spinal
cord of amniotes.
In this study, we show that the tran-
scription factor Neurog3, which is ex-
pressed in the mouse ventral spinal cord
(Sommer et al., 1996; Lee et al., 2003) but
not in zebrafish spinal cord (Wang et al.,
2001), controls the correct specification of
p3-derived neurons by suppressing sero-
tonergic neuron production. We provide
strong genetic evidence that Neurog3 en-
sures the assignment of V3 identity by
reducing Ascl1 expression through a
mechanism that involves the transcrip-
tional repressor Hes5. In the absence of
Neurog3, spinal p3 progenitors fail to
adopt a complete caudal character, which
results in heterotopic development of se-
rotonergic neurons at the expense of V3
interneurons.
Materials andMethods
Animals. All experiments involving animals
were conducted according to the protocols approved by the Institutional
Animal Care and Use Committee of the Fundacio´n Instituto Leloir.
Genotyping of Neurog3 (Gradwohl et al., 2000), Ascl1 (Guillemot et al.,
1993),Nkx2.2 (Briscoe et al., 1999),Ascl1CreER (Kim et al., 2011), Sim1Cre
(Zhang et al., 2008), UncxlacZ (Mansouri et al., 2000), CAG:CreER
(Hayashi and McMahon, 2002), Ascl1flox (Pacary et al., 2011), Gata2GFP
(Suzuki et al., 2006), and Ai14 tdTomato conditional reporter (Madisen
et al., 2010)micewere performedbyPCRusing allele-specific primers for
each strain.
Time pregnancies were determined by detection of vaginal plug and
midday was designated E0.5. Induction of Cre activity in Ascl1CreERmice
was achieved by tamoxifen administration (TAM; 150 mg/kg b.w., i.p.)
to pregnant females at the indicated stages.
Embryos were dissected in PBS buffer. After decapitation, embryos
were pinned on Sylgard plates, eviscerated, and fixed for 1 h in 4%PFA in
PBS. They were cryoprotected in 20% sucrose (overnight, 4°C) before
embedding in Cryoplast (Biopack). Stage-matched littermates of desired
genotypes were aligned and embedded together to ensure identical pro-
cessing conditions. Tissue was cryosectioned 30 m thick (Leica 3050S;
Leica Biosystems).
In situ hybridization and immunohistochemistry. Nonradioactive in
situ hybridization was performed essentially as previously described
(Lanuza et al., 2004). Briefly, sections were dried at 55°C for 20min, fixed
15 min with PFA 4% in PBS, and washed three times with PBS-DEPC.
Tissue was treated 3 min with proteinase K (3 g/ml), followed by
PFA 4% 10 min and three PBS washes. Slides were incubated in
triethanolamine-acetic anhydrate pH 8.0 for 10 min, permeabilized with
Triton X-100 1% in PBS for 30min, and washed with PBS. Sections were
incubated for 2 h with hybridization solution (50% formamide, 5 SSC,
5 Denhardt solution, and 250 g/ml yeast tRNA). DIG-labeled RNA
probes were generated by in vitro transcription using T7, T3, or sp6 RNA
polymerases (Promega), DIG-UTP (Roche), rNTPs (Promega), and
PCR-amplified products or linearized plasmids as templates. RNA
probes used were mNeurog3 (this study), mSim1 (Zhang et al., 2008),
mUncx (Mansouri et al., 2000), mAscl1 (Kriks et al., 2005), mNkx2.2
(Briscoe et al., 1999), mGata2 (this study), mLmx1b (Cheng et al., 2003),
ratPet1 (Fev; Hendricks et al., 1999), mvGluT2 (Slc17a6; Lanuza et al.,
2004), mSerT (Slc6a4; this study), mvGluT3 (Slc17a8; Cheng et al.,
2003), mHes5 (Hojo et al., 2000), mvAChT (Slc18a3; Zhang et al., 2008),
chickSim1 (this study), chickAscl1 (Tsarovina et al., 2004), chickNeu-
rog3 (this study), and chickHes5-1 and 5-2 (Fior and Henrique, 2005).
DIG-labeled probes were diluted in hybridization solution, denatured
at 80°C for 5min, and added on the slides. Incubation was performed for
14 h at 68°C. Sections were washed three times, 45 min, at 68°C with 1
SSC, 50% formamide. For immunodetection of DIG, slides were blocked
with 10% HI-serum in PBS containing 0.1% Tween 20 for 1–2 h (room
temperature, RT) and incubated overnight at 4°C with alkaline
phosphatase-labeled sheep anti-DIG antibody (Roche) diluted in block-
ing solution. After washing 3 10 min, enzymatic activity was detected
by using BCIP (0.15 mg/ml; Roche) and NBT (0.18 mg/ml; Roche) in
reaction solution (Tris, pH 9.5, 0.1 M, MgCl2 50 mM, NaCl 0.1 M, and
Tween 20 0.1%). Bright-field pictures were captured by digital camera on
Zeiss Axioplan microscope.
Antibody stainings were performed essentially as previously described
(Lanuza et al., 2004). Briefly, cryostat sections werewashed three times in
PBS containing 0.1% Triton X-100 (PBST) and treated with blocking
solution (5% HI-serum in PBST) for 1 h. Primary antibodies at the
appropriate dilutions in blocking solution were incubated overnight at
4°C. The following antibodies were used: mouse anti-Neurog3, mouse
anti-Nkx2.2, mouse anti-Nkx6.1, mouse anti-Isl1/2 (Developmental
Studies Hybridoma Bank, DHSB), mouse anti-Ascl1 (BD Biosciences),
rabbit anti-Nkx2.2 (Tom Jessell, Columbia University, NY), goat anti-
Sox2 (Santa Cruz Biotechnology), mouse anti-III-tubulin (Sigma),
rabbit anti-Olig2 (Millipore Bioscience Research Reagents), mouse anti-
Foxa2 (Abcam), chicken anti--gal (Abcam), rabbit anti-GFP (Invit-
rogen), chicken anti-GFP (Aves Laboratories), rabbit anti-dsRed
(Clontech), rabbit anti-5HT (ImmunoStar), mouse anti-Cre (Sigma),
and rabbit anti-Lhx3 (Sam Pfaff, The Salk Institute, La Jolla, CA).
After incubation, slides were washed 3 10 min each with PBST and
incubated with Cy-labeled, species-specific secondary antibodies (Jack-
son ImmunoResearch) for 2–3 h at RT. Sections were dehydrated in
ethanol/xylene series and mounted using DPX (Sigma-Aldrich). Images
Figure 1. Neurog3 is expressed in the ventral spinal cord p3 domain. A–I, Hindbrain serotonergic and spinal V3 interneurons
arise from ventral p3 progenitors. Hindbrain and spinal cord E11.5 cross sections were hybridized with probes against the p3
markerNkx2.2 (A); serotonergic-specific transcription factors Gata2 (B), Lmx1b (C), andPet1 (D); andV3 transcription factors Sim1
(E) andUncx (F ). Serotonergic hindbrain neuronswere identified by immunostaining against 5-HT (G), and aprobe against vGluT2
(H )was used to identify glutamatergic neurons in the spinal cord. Arrowheads point to p3 cells or p3-derived postmitotic neurons.
I, Schematic representation of p3-derived cells in distinct regions of theneural tube: serotonergic neurons in thehindbrain (5HT-N)
and glutamatergic V3 interneurons in the spinal cord (top). The transcription factors expressed in serotonergic and V3 neuron
differentiation are shown (bottom). J–N, Neurog3 is expressed in the spinal p3 ventricular zone but is absent in the ventral
hindbrain. Cross sections of E10.5 hindbrain and spinal cordwere hybridizedwith aNeurog3 probe (J,K ) and immunolabeledwith
Neurog3 and Nkx2.2 antibodies (L, M ). Note that while Neurog3 is robustly expressed in Nkx2.2 spinal cord ventral cells
(arrowhead inK,M ), it ismissing in the hindbrain (arrowhead in J, L). Low levels of Neurog3 expressionwere found dorsally to the
p3domain (arrow inK ). Thenumber ofNeurog3 cells per section that coexpressNkx2.2 is shown (N ). Bars aremean SD. Scale
bars: 50m.
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were captured using Zeiss LSM5Pascal and Zeiss LSM510Meta confocal
microscopes and assembled using Adobe Photoshop and Adobe
Illustrator.
In ovo electroporation. Full-length cDNA of mNeurog3 and cHes5-1
(provided by Domingos Henrique; Fior and Henrique, 2005) were
cloned into pCAG-IRES-EGFP vector. Dominant-negative retinoic acid
receptor hRAR403 expression plasmid (provided by Shan Sockanathan)
and CAG-rAscl1-ires-GFP construct were previously used (Sockanathan
et al., 2003; Kriks et al., 2005). Chick electroporation was performed
essentially as described previously (Muramatsu et al., 1997).
Quantitations and statistical analysis. At least six sections were exam-
ined from each embryo, and no less than three embryos of each genotype
were used. Thoracic and upper lumbar spinal cord segments and r6–r7
rhombomeres were analyzed.
Integration of in situ hybridization signals was performed using a
MATLAB (The MathWorks) script on nonprocessed images. Back-
ground levels were defined by the mean intensity along the perimeter of
the selected area and positive pixels were defined as those above back-
ground mean 2 standard deviations (SD).
Ascl1 expression levels were assessed using a MATLAB script that
measured the mean intensity of individual nuclei. Ascl1 intensity of cells
located within the p3/Nkx2.2 domain was corrected by subtracting
background levels. For each section, background intensity was deter-
mined as the mean intensity of 10 progenitor cells located in the mo-
toneuron progenitor domain (pMN), which do not express Ascl1. A cell
was considered “HIGH”when its intensity was above themean 1 SDof
wild-type spinal p3 Ascl1 intensity.
Differences between groups were evaluated
by nonparametric Mann–Whitney test or
Kruskal–Wallis ANOVA with post hoc Dunn’s
multiple-comparison test (GraphPad Software).
Results were considered statistically significant
whenp0.05.DataarepresentedasmeanSD.
Results
Neurogenin3 is expressed in the spinal
cord p3 domain
Ventral p3 progenitors of the mouse
hindbrain and spinal cord produce 5-HT
neurons and V3 interneurons, respec-
tively (Fig. 1A–I). In the developing ven-
tral hindbrain, the expression of the
transcription factors Gata2, Lmx1b, and
Pet1 delineate the differentiation of sero-
tonergic neurons (Fig. 1A–D,G), whereas
in the spinal cord, Nkx2.2 progenitors
produce glutamatergic V3 neurons that
are identified by the transcription fac-
tors Sim1 and Uncx (Fig. 1A,E,F,H ). In
searching for intrinsic controllers of these
divergent neuronal fates, we first explored
the spatial and temporal pattern of ex-
pression of the bHLH transcription factor
Neurog3. In E10.5 embryos, Neurog3 ex-
pression was found largely restricted to
themost ventral domain of the spinal cord
(Fig. 1K). Immunohistochemical analysis
with antibodies against Neurog3 and
Nkx2.2 showed that all Neurog3-expressing
cells in the developing spinal cord are
Nkx2.2 positive (Fig. 1M,N). Neurog3 is
not homogenously expressed in all
Nkx2.2 cells, with Neurog3 cells occu-
pying lateral positions within the spinal
p3 ventricular zone (Fig. 2E–J). This sug-
gests that Neurog3 is either oscillatory or
preferentially expressed in committed
precursors, similar to the expression patterns seen for other
bHLH proteins (Bertrand et al., 2002; Imayoshi and Kageyama,
2014). In contrast to the robust expression of Neurog3 in the p3
domain of the embryonic spinal cord, topographically related
p3 progenitors of the hindbrain are negative for Neurog3 (Fig.
1J–N ).
In the spinal cord, Neurog3-expressing cells are embedded in
Nkx6.1 domains (Fig. 2A), positioned ventral to motoneuron pro-
genitors that are marked by the expression of Olig2 and Lhx3 (Fig.
2B,C), and excluded from the floor plate (Foxa2HIGH; Fig. 2D).
Neurog3 expression in the ventral spinal cord is limited to the ven-
tricular zone, as indicated by colabeling with the progenitor cell
marker Sox2 (Fig. 2E) and its exclusion from III-tubulin new-
born neurons (Fig. 2F). Furthermore, Neurog3 in the p3 domain of
the spinal cord precedes the appearance of the transcription factors
Sim1 and Uncx, which are both induced in newly generated neu-
rons as they leave the ventricular zone and acquire postmitotic
V3 neuronal identity (Fig. 2G–J ). The absence of double label-
ing of Neurog3 and Cre in the Sim1Cre neural tube, and Neu-
rog3 and -galactosidase inUncxlacZ knockinmice, argues that
Neurog3 is rapidly downregulated during V3 neurogenesis.
The limited expression of Neurog3 to the ventrocaudal neural
tube suggests that it lays downstream of signals acting along the
Figure 2. Neurog3 delineates spinal cord p3 precursors. A–D, Neurog3 is expressed in the spinal p3 domain. Immunostainings
on E10.5 spinal cord sections revealed that Neurog3 cells are restricted to Nkx6.1 territories (A), ventral to the domain that
gives rise to motoneurons, marked by Olig2 (B) and Lhx3 (C), and excluded from the Foxa2 HIGH floor plate (D). Dotted lines
represent dorsoventral boundaries. E, F, Neurog3 is expressed before neuronal differentiation. Immunohistochemistry against
Neurog3 on E10.5 spinal cord sections show coexpression with the progenitor marker Sox2 (E), but absence in -III-tubulin
newborn neurons (F ). Ventricle to the left. G–J, Neurog3 precedes V3 differentiation. Sim1 (anti-Cre antibody, G, H ) and Uncx
(anti--galactosidase antibody, I, J ) were analyzed in Sim1Cre/ and UncxlacZ/ E11.5 spinal cords, respectively. Ventricle to the
left in H and J. K, Neurog3 expression depends on retinoid activity. In situ hybridization with a cNeurog3 probe on E4 chick spinal
cord sections thatwereelectroporatedwithadominant-negativeRAR403-IRES-GFPexpression construct at E3.GFP labeling shows
the targeted region. Arrowhead points to Neurog3 reduced expression. L, M, Neurog3 expression is regulated by Nkx2.2. Immu-
nostaining against Neurog3 and Nkx2.2 on E10.5 spinal cord sections from wild-type, Nkx2.2, or Pax6 mutant embryos. Nkx2.2
mutants lack Neurog3 in the ventral spinal cord. Arrow points to one Neurog3 cell found (L, middle). The expanded Nkx2.2
territory in Pax6mutants induces a dorsal extension of Neurog3 cells (L, right).M, Number of Neurog3 cells per section. Bars
are mean SD. Scale bars: A–D, G, I, K, L, 50m; E, F, H, J, 20m.
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orthogonal axes of the developing ner-
vous system. In viewof thepreeminent role
that retinoid signaling plays in the anterior–
posterior patterning of the neural tube and
serotonergic neuron development (Muhr
et al., 1999; Liu et al., 2001; Maden, 2006;
Jacob et al., 2013), we asked if retinoid
signaling contributes to restrict Neurog3
to the spinal cord. In keeping with previous
experiments showing an anterior-low,
posterior-high gradient of retinoic acid in
the hindbrain–spinal cord (Maden, 2006;
Jacob et al., 2013), electroporation of a
dominant-negative version of the retinoic
acid receptor (RAR403; Sockanathan et al.,
2003) in the chick spinal cordmarkedly de-
creasedNeurog3 levels (Fig. 2K), suggesting
that Neurog3 is under the control of reti-
noid signaling.On theotherhand, the selec-
tive expression of Neurog3 to the most
ventral domain of the spinal cord depends
on the transcription factor Nkx2.2, which is
induced by sustained Shh signaling (Briscoe
et al., 1999; Dessaud et al., 2007). The spinal
cord of Nkx2.2 mutants lacks ventral cells
that express high levels of Neurog3 (Fig.
2L,M). Conversely, the expansion of the
p3/Nkx2.2 domain in Pax6 mutant em-
bryos (Ericson et al., 1997; Briscoe et al.,
1999) resulted in an increased number of
Neurog3 cells that spread dorsally (Fig.
2L,M).
Interplay between Neurog3 and Ascl1
establishes the caudal boundary for
serotonergic specification
Recent studies indicate that the expres-
sion level of the bHLH transcription fac-
tor Ascl1 strongly influences the choice
between serotonergic and V3 cell fates
with Ascl1 highly expressed in the hind-
brain (Pattyn et al., 2004; Jacob et al.,
2013). This suggests that the suppression
of Ascl1 expression in caudal neural tube
is a key step in establishing the glutama-
tergic V3 cell differentiation program.We
first compared the expression of Neurog3
and Ascl1 in the p3 domain of the spinal
cord throughout development. Neurog3
is initially absent from this domain at
E9.5, and begins to be expressed at ap-
proximately E10 (Fig. 3A,D). Ascl1, on
the other hand, displays an inverse tem-
poral pattern. It is robustly expressed in
Nkx2.2 spinal cells at E9.5, but is sharply
downregulated at later stages (Fig. 3B,E).
The dynamic pattern of Ascl1 in the developing spinal cord was
also analyzed in Ascl1CreER;CAG:floxstop-tdTomato mice. By ret-
rospectively evaluating Ascl1 expression at E11.5, we detected
p3-derived tdTomato cells when tamoxifen was administered
at E9.5 (Fig. 3G, arrowhead), but not when induced at E10.5 (Fig.
3G). This downregulation of Ascl1 in the spinal cord p3 domain
contrasts with Ascl1 expression in the hindbrain (Pattyn et al.,
2004), where it remains elevated from E9.5 to E11.5 (Fig. 3C).
Measurement of Ascl1 intensity in individual p3 cells of the hind-
brain and spinal cord at E11.5 reflected quantitative differences in
Ascl1 levels (Fig. 3F) as previously shown (Jacob et al., 2013).
We then mapped Neurog3 and Ascl1 expression along the
rostrocaudal axis of the E11.5 neural tube. As shown above (Fig.
1J–N), Neurog3 expression was restricted to the spinal cord p3
Figure 3. Neurog3 and Ascl1 inversely correlate in the ventral neural tube.A–E, Neurog3 and Ascl1 have a dynamic expression
pattern in the ventral spinal cord. Immunohistochemistry against Neurog3 andAscl1 shows thatNeurog3 cells increase in the p3
domain from E9.5 to E11.5 (A), while Ascl1 expression decreases (B). Ascl1 in the ventral hindbrain remained constant throughout
development (C).D–E, Number of Neurog3 or Ascl1 HIGH cells in the spinal cord at the indicated stages. F, Measurement of Ascl1
intensity in p3 progenitors of the hindbrain or spinal cord at E11.5. The dashed line is the threshold for considering cells Ascl1 HIGH
in E (see Materials and Methods); ***p 0.001, Mann-Whitney test. G, Spinal p3 cells express Ascl1 at E9.5 but not at E10.5. In
Ascl1CreER;CAG:floxstop-tdTomato embryos; Cre was induced at E9.5 or at E10.5 with TAM. E11.5 spinal cord sections were stained
against tdTomato. At E11.5, spinal p3-derived tdTomato cells were found only when Cre was activated at E9.5 (arrowhead).
H–K, Serotonergic and V3 differentiation strictly correlates with Neurog3 and Ascl1-expressing territories.H, I, Relative numbers
of p3-derivedneuron types: serotonergic (5HT-N)orV3 interneurons (H ) andp3 cells expressingNeurog3orAscl1 HIGH (I ) along the
rostrocaudal axis at E11.5. Serotonergic differentiation was determined by GFP-expressing cells in the Nkx2.2 domain of
Gata2GFP embryos (immunostaining), while V3 interneurons were identified by Sim1 expression (in situ hybridization). The pink
area denotes the transition between the hindbrain and the spinal cord shown in the scheme. Cell numbers or signal intensity along
the anterior–posterior axis weremade relative to the sectionswithmaximumnumber ormaximum intensity. Points aremean
SD. J, K, Representative images of Ascl1 (J ) and Neurog3 (K ) immunostainings at indicated rostrocaudal coordinates. L–O,
Serotonergic specification is impaired in Ascl1 mutants, while spinal V3 neurons are not affected. In situ hybridizations on E11.5
cross sections. The serotonergic-related transcription factors Gata2 (L) and Pet1 (M ) were not detected in the hindbrain of
Ascl1/, whereas the V3 identity markers Sim1 (N ) and Uncx (O) remained unmodified in the spinal cord of Ascl1 mutants.
Arrowheads point to p3 cells o3 p3-derived postmitotic neurons. Bars aremean SD. Dotted lines represent the dorsal boundary
of the Nkx2.2 domain in the same section. Scale bars: 50m.
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domain and excluded from the hindbrain
(Fig. 3I). On the contrary, Ascl1 was ro-
bustly expressed in hindbrain p3 progen-
itors, and only at low to undetectable
levels in spinal p3 ventricular cells (Fig.
3 I,F; Jacob et al., 2013). In the hindbrain–
spinal cord transition, we observed a sharp
inversion in the numbers of Neurog3 and
Ascl1HIGHcells (Fig.3I–K,pinkarea),withthe
Ascl1- and Neurog3-expressing territories
strictly corresponding to those that give rise to
serotonergic and V3 interneurons, respec-
tively (Fig. 3H).
We then investigatedwhether thisdiffer-
ential anterior–posterior Ascl1 expression
correlateswith specific anddifferent roles in
neuronal specification.Consistentwithpre-
vious reports that showed that serotonergic
differentiation requires Ascl1 (Pattyn et al.,
2004), we found that ventral hindbrain of
Ascl1 mutants lack expression of the tran-
scription factors Gata2 and Pet1 (Fig.
3L,M). In contrast,we found that Sim1and
Uncx were largely unaffected in Ascl1/
spinal cord (Fig. 3N,O), demonstrating that
Ascl1 in the ventral spinal cord is dispens-
able for V3 interneuron specification.
Together, our results show that early
p3 progenitors initially express high levels
of Ascl1 along the entire length of the neu-
ral tube, and that the upregulation of
Neurog3 in spinal p3 cells coincides with
Ascl1 downregulation. In the hindbrain,
the absence of Neurog3 correlates with
Ascl1 maintenance, and the consequent
serotonergic differentiation.
Neurog3 represses Ascl1 expression and
switches from serotonergic to
glutamatergic neurogenesis
To better understand how the comple-
mentary Neurog3 and Ascl1 expression
patterns are established, we performed
gain-of-function experiments by in ovo
electroporation in the chick embryo,
where the dynamics of Neurog3 expres-
sion is similar to the mouse (Fig. 4A–C).
First, Neurog3 was misexpressed early
during spinal cord development, preced-
ing the endogenous induction of Neurog3
(Fig. 4B). Electroporation of a Neurog3-
IRES-GFP plasmid into E2 chick neural
tube reduced ventral spinal cord Ascl1
levels, compared with the contralateral un-
electroporated side (Fig. 4D) or to the elec-
troporation of a control GFP vector (not
shown). Furthermore, forced expression of
Neurog3 in the ventral hindbrain, where
Neurog3 is absent (Fig. 4A), consistently
suppressed Ascl1 expression (Fig. 4E,F),
without affecting the dorsoventral exten-
sion of the p3 domain as assessed byNkx2.2
immunostaining (Fig. 4E, inset).
Figure 4. Neurog3 regulates Ascl1 expression by a mechanism involving Hes5. A–C, The spatial and temporal Neurog3 expression
pattern is similar in chick andmouse embryos. Sections of chick E3–E5 ventral hindbrain (A) and spinal cord (B) were hybridized with a
probeagainst cNeurog3.Neurog3expressionwas found in thespinal cordbeginningatE4,butabsent in theventralhindbrainatall stages.
Neurog3expressionpattern in themouse spinal cord (E9.5–E11.5;C) is included for comparison.D,E, Neurog3 repressesAscl1expression.
E2 chick embryos electroporated with Neurog3-IRES-GFP into the ventral spinal cord (D) or hindbrain (E) showed reduced Ascl1 mRNA
levels analyzed at E3 (arrowheads). No changes were found in Nkx2.2 expression assessed by immunohistochemistry (inset in E). GFP
labelingshowstargetedregion.F,Neurog3misexpressionchangesneuronal identity inthehindbrain.CrosssectionsofE5ventralhindbrain
electroporatedwithNeurog3were stainedwithantibodies againstGFPand5-HT, andhybridizedwithprobesagainstAscl1 andSim1. The
electroporated side showed reduced Ascl1 levels, suppressed serotonergic specification, and a moderate induction of the V3 neuronal
marker Sim1 (arrowheads). G, Coelectroporation of Neurog3 and Ascl1 expression vectors restores 5-HT neuron differentiation in the
ventralhindbrain (arrowhead). Cotransfectedcross sectionsofE5hindbrainwerestainedwithantibodiesagainstGFPand5-HT.H, Altered
neuronaldifferentiation in thehindbrainafterHes5misexpression.Cross sectionsofE5chickhindbrainelectroporatedwithHes5-IRES-GFP
werehybridizedwithanAscl1probeand labeledwithanantibodyagainst5-HT.TheelectroporatedsideshowedreducedAscl1expression
and a suppression of serotonergic differentiation. I, Increased Hes5 levels in the ventral hindbrain after Neurog3misexpression. E2 chick
embryoswere electroporatedwith Neurog3-IRES-GFP and hybridizedwith cHes5-1 and cHes5-2 probes at E3. In the control side, Hes5 is
mildlyexpressed in thep3domain (arrow)while induced in theelectroporatedside (arrowhead).GFPstaining reveals the targeted region.
J,K, Hes5 expression in the ventral spinal cord depends on Neurog3. E11.5 spinal cord cross sections fromwild-type andNeurog3mutant
mice showed reduced Hes5 mRNA levels in the Neurog3/ spinal p3 domain (J ). Arrowheads point to p3 domain, arrows point to
intermediatedorsalprogenitors.QuantitationofHes5levelsinthep3domain(K ).BarsaremeanSD;**p0.01,Mann–Whitneytest.Schemes
ofrelationsbetweenNeurog3,Hes5,Ascl1,anddifferentiationof5-HTneuronsareshown.Scalebars:50m.
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As development proceeds, repression
of Ascl1 elicited by Neurog3 electropora-
tion in the hindbrain was followed by a
marked reduction in the number of sero-
tonergic neurons (Fig. 4F). In these em-
bryos, the decrease in 5-HT cells was
accompanied by the ectopic production
of V3-Sim1 neurons in the hindbrain
(Fig. 4F ). To assess if the reduced
serotonergic differentiation induced by
Neurog3 required Ascl1 repression, we
coelectroporated Neurog3 and Ascl1, and
found that serotonergic neurogenesis was
restored (Fig. 4G). These results show that
ectopic overexpression of Neurog3 in the
ventral hindbrain forces the acquisition of
a spinal p3 identity in which reduced
Ascl1 levels anticipate the suppression of
serotonergic specification. Furthermore,
the heterochronic expression of Neurog3
in the spinal cord (Fig. 4D) suggests that
the role of Neurog3 is to reduce Ascl1 ex-
pression levels in spinal p3 progenitors,
which allows the subsequent differentia-
tion of glutamatergic V3 neurons.
Hes5 mediates Neurog3-dependent
Ascl1 repression
To gain further insights into the mecha-
nism underlying Ascl1 repression byNeu-
rog3 in p3 spinal progenitors, we analyzed
Hes proteins, which are transcriptional
repressors of Ascl1 that usually act down-
stream of Notch signaling (Bertrand et al.,
2002; Kageyama et al., 2007). The comple-
mentary Ascl1 and Hes5 patterns along
the p3 domain (Jacob et al., 2013) resem-
ble the reciprocal expression of Ascl1 and
Neurog3 (Fig. 3I). This correlation sug-
gests that themodulation ofAscl1 byNeu-
rog3 in spinal p3 progenitors could
functionally involve Hes5.
The electroporation of Hes5 in the de-
veloping chick hindbrain was seen to
downregulate Ascl1 in the p3 domain and
to suppress 5-HT neuron specification
(Fig. 4H). To test whether Neurog3 could
regulate Ascl1 viaHes5, we electroporated
Neurog3 in the chick hindbrain and as-
sessed Hes5 expression. Misexpression of
Neurog3 induced Hes5-1 and Hes5-2 ex-
pression in the transfected hindbrain p3
domain (Fig. 4I, arrowhead), in contrast
to the nonelectroporated side where there is a gap in Hes expres-
sion (Fig. 4I, arrow). Interestingly, the induction ofHes5 byNeu-
rog3 was not restricted to the hindbrain, since Hes5 upregulation
was also evident when Neurog3 was targeted into the spinal cord
(data not shown). Consistent with the finding that Neurog3 is
able to induce Hes5,Neurog3mutant embryos show significantly
reduced Hes5 levels in the spinal p3 domain (Fig. 4J, arrowhead,
K), while its expression in more dorsal ventricular progenitors
remained normal (Fig. 4J, arrow). These results provide strong
evidence that Hes5 repressor proteins function downstream of
Neurog3 to elicit Ascl1 downregulation in p3 spinal progenitors.
We propose that this step is necessary to produce the full com-
plement of glutamatergic V3 neurons (see below).
Ascl1 is maintained at high levels in spinal p3 precursors in
Neurog3 mutants
To address whether Neurog3 plays a physiological role in regu-
lating Ascl1 expression in the ventral spinal cord and, in turn,
neuron identity, we analyzed the Neurog3 mutant ventral spinal
cord and found amarked increase in the number of cells express-
Figure 5. Sustained Ascl1 expression in the Neurog3 mutant spinal cord without changes in dorsoventral patterning. A–E,
Neurog3 is necessary to downregulate Ascl1 in the spinal cord. Wild-type and Neurog3/ E11.5 sections were stained with
antibodies against Ascl1 (A) andNkx2.2 (D). The number of Ascl1 cellswas increased inNeurog3/ p3 spinal cord (arrowhead,
A), without changes in the number of Nkx2.2 cells (D). Quantitation of the number of Ascl1 HIGH (B) and Nkx2.2 (E) cells in the
p3 spinal cord. Bars aremean SD. C, Quantitative differences in Ascl1 intensity in individual p3 progenitor cells ofwild-type and
Neurog3-null spinal cords. Dashed line indicates the threshold for considering cells as Ascl1 HIGH in B; ***p 0.001, Mann–
Whitney test. F,G, Dorsoventral patterning is not affected inNeurog3mutants. The expression of Olig2 (pMN domain) and Nkx2.2
(p3 domain) were assessed by immunohistochemistry in Neurog3 mutant E10.5 spinal cords. Dorsoventral positioning of the
boundaries wasmade relative to the length of the ventricular aperture (100%) in the same sections (G). Boxes aremean limits
SD. H–J, Motoneuron development is not modified in Neurog3/. Immunohistochemistry against Isl1/2 (H ), in situ hybridiza-
tion with a probe against the vesicular acetylcholine transporter (vAChT; I ), and quantitation of the number of Isl1/2 cells per
hemisection (J ) ofwild-typeandNeurog3/ E10.5 spinal cord.K, L, Foxa2expressionwasunaffected inNeurog3/ spinal cord.
Foxa2 was detected by immunohistochemistry on E11.5 hindbrain and spinal cord sections. In thewild-type hindbrain high levels
of Foxa2 are found in the p3 domain (K, left), while it is expressed at low levels in the spinal p3 domain ofwild-type and Neurog3
mutants (K, center and right). Quantitation of Foxa2 levels relative to the expression in the floor plate of the same sections (L).
Boxes are mean SD. Dotted lines indicate the boundaries of the Nkx2.2 territory in the same section. Scale bars: 50m.
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ing high levels of Ascl1 (Fig. 5A,B). Quantitative analysis in in-
dividual spinal cells revealed that Ascl1 levels in Neurog3/ p3
cells are significantly higher than in their wild-type littermates
(Fig. 5C) and similar to Ascl1 levels in the p3 hindbrain (Fig. 3F).
This result demonstrates that Neurog3 expression in the spinal
cord, which starts around E10 (Fig. 3A,D), is essential to achieve
the low levels of Ascl1 that are a defining feature of spinal p3
progenitors. Interestingly, the loss of Neurog3 does not affect
the number of Nkx2.2 cells in the neural tube (Fig. 5D,E) nor
the position of the p3-pMNboundary (Fig. 5F,G).Moreover, the
motoneuron population in the Neurog3/ spinal cord is not
altered (Fig. 5H–J), and the expression of Foxa2 in p3 cells is
retained at low levels, similar to wild types (Fig. 5K,L). Thus,
Neurog3 is not required for dorsoventral identity, but is neces-
sary to limit the expression of Ascl1 in spinal p3 cells, which
otherwise would acquire a rostral hindbrain character.
The mutual exclusion between Neurog3 and Ascl1 prompted
us to test whether Neurog3 and Ascl1 function in a cross-
repressive fashion. However, we found that the repressive inter-
action betweenNeurog3 andAscl1 is asymmetrical. NeitherAscl1
mutants, nor conditional mutant embryos in which Ascl1 was
acutely deleted by tamoxifen (CAG:CreER;Ascl1flox/flox), showed
Neurog3 expression in the ventral hindbrain (Fig. 6A–D). In ad-
dition, in the Ascl1 mutant spinal cord Neurog3 expression still
starts around E10, similar to wild-type embryos (Fig. 6E–H).
These experiments rule out a scheme of reciprocal inhibition
between Neurog3 and Ascl1, but support a model in which Neu-
rog3 represses Ascl1 in the developing spinal cord.
Neurog3 suppresses 5-HT fate in the spinal cord
Serotonergic raphe neurons are produced exclusively from ven-
tral hindbrain p3 progenitors that express the transcription fac-
tors Nkx2.2 and Foxa2, which together with Ascl1 are required
for their specification (Briscoe et al., 1999; Pattyn et al., 2004;
Jacob et al., 2007, 2013). To address whether the persistent Ascl1
expression in the spinal cord of Neurog3mutants is indicative of
the acquisition of rostral/hindbrain identity, we asked whether
spinal progenitors that normally give rise to glutamatergic V3
neurons are redirected into a serotonergic differentiation
program.
We found that high levels of Ascl1 in Neurog3/ spinal p3
cells (Figs. 5A–C, 7A) are closely associated with the ectopic ex-
pression of Gata2, Lmx1b, and Pet1 (Fig. 7B–D), which are key
transcription factors of the postmitotic genetic program driving
serotonergic fate (Hendricks et al., 1999, Hendricks et al., 2003;
Cheng et al., 2003; Ding et al., 2003; Craven et al., 2004) and are
never expressed in Nkx2.2-derived cells of the spinal cord (Fig.
1B–D).
The generation of ectopic spinal serotonergic neurons inNeu-
rog3 mutants was in all cases entirely restricted to the ventral
neuroepithelium. To determine whether ectopic serotonergic
neurons in Neurog3-null spinal cords require Nkx2.2, as do
5-HT-neurons in the hindbrain (Briscoe et al., 1999; Cheng et al.,
2003; Pattyn et al., 2003), we generated Nkx2.2/Neurog3 and
Pax6/Neurog3 double mutants. Nkx2.2/Neurog3 double knock-
outs did not show signs of ectopic 5-HTneuron differentiation in
their spinal cord (Fig. 7E–H). This contrasts starkly with Pax6/
Neurog3 doublemutants that have an extendedNkx2.2 domain
(Fig. 2L) and display a 2-fold increase in the expression of
Ascl1, Gata2, Lmx1b, and Pet1 compared with the simple Neu-
rog3 knock-out (Fig. 7E–H).Together, these results confirm that
ectopic spinal serotonergic neurons originate fromNkx2.2 cells
in the absence of Neurog3. These experiments also demonstrate
that spinal p3 cells are bipotential progenitors, which when lack-
ing Neurog3 adopt the transcriptional program that specifies se-
rotonergic neurons in the ventral hindbrain (Deneris andWyler,
2012).
To further characterize the heterotopic serotonergic neurons
in the spinal cord ofNeurog3mutants, we assessed the presence of
5-HT and found immunoreactive neurons in the ventral spinal
cord of Neurog3/ E12.5 embryos and P0 pups (Fig. 7 I, J).
5-HT intraspinal processes were also identified in the ventro-
lateral funiculus at E12.5 (Fig. 7I, arrows), when hindbrain sero-
tonergic projections have not reached the thoracic and upper
lumbar segments analyzed. In addition, inspection of Neu-
rog3/P0 animals showed that ectopic 5-HTneurons locate in
the ventromedial and ventrolateral spinal cord and project locally
through the ventral funiculus (Fig. 7K–M). Moreover, Neu-
rog3/ spinal cords display ectopic induction of the serotonin
transporter SerT (Fig. 7N), together with the vesicular glutamate
transporter vGluT3 (Fig. 7O), which is a specific marker of 5-HT
neurons (Cheng et al., 2003).
Finally, we found that the ectopic generation of serotonergic
neurons in the spinal cord ofNeurog3mutants is produced at the
expense of glutamatergic V3 interneurons. The analysis of the V3
identity markers Sim1 and Uncx showed that the spinal cord of
Neurog3/ displays a 50% reduction in these transcription
factors (Fig. 8A,B,D,E; Lee et al., 2003). In addition, the decreased
number of glutamatergic V3 neurons in the spinal cord of Neu-
rog3mutants is made evident by a significantly lower expression
of the vesicular glutamate transporter vGluT2 (Fig. 8C,F). In the
absence of Neurog3, spinal p3 progenitors produce both V3/
Figure 6. Neurog3-Ascl1 repression is unidirectional. A–D, Neurog3 is not expressed in the
hindbrain of Ascl1 mutants. E11.5 (A) or E10.5 (B) cross sections of wild-type and Ascl1/
hindbrainwere stainedwith an antibody against Neurog3. C, Acute deletion of Ascl1 by TAM at
E10 in CAG:CreER;Ascl1flox/flox embryos did not result in Neurog3 expression in the E11.5 hind-
brain (C, left). Immunostaining of Ascl1 after TAM induction shows a reduction in Ascl1-
expressing cells (arrows, C, right; see Fig. 3C for comparison). D, The analysis of Neurog3
expression along the anterior–posterior axis of E11.5 wild-type and Ascl1 mutant mice do not
show signs of rostral shift in Neurog3 expression. Points aremean SD. Nonsignificant differ-
ences were found between groups. E–H, Ascl1 does not control the onset of Neurog3 in the p3
spinal cord. Cross sections of E9.5, E10.5, and E11.5 spinal cords ofwild-type (E) and Ascl1/
(G) mice were stained with an anti-Neurog3 antibody. The appearance of Neurog3 (approxi-
mately E10)was not significantly affected inAscl1mutants. F,H, Quantitation of the number of
Neurog3 cells at indicated stages in wild-type (F ) and Ascl1/ (H ) spinal cords. Bars are
mean SD. Dotted lines represent the dorsal boundary of the Nkx2.2 domain in the same
section. Scale bars: 50m.
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Sim1 cells and Gata2/Pet1 seroto-
nergic neurons (Fig. 8G), and later each
neuronal population follows distinctive
migratory pathways, as shown at E12.5
(Fig. 8H). It is noteworthy that the posi-
tion of newly generated ectopic 5-HT
neurons at E11.5, proximal to the ventric-
ular zone, may reflect that they are prefer-
entially produced in a delayed neurogenic
wave, similar to their development in the
hindbrain (Pattyn et al., 2003; Jacob et al.,
2007).
Discussion
In this study, we show that the transcrip-
tion factor Neurog3 controls cell identity
in the p3 domain of the spinal cord where
it suppresses serotonergic specification.
The restricted expression of Neurog3 in
ventral spinal p3 cells results from the
composite activities of ventralizing and
caudalizing signals. Neurog3 depends
both on Nkx2.2, in response to high and
prolonged Shh signaling (Briscoe et al.,
1999; Dessaud et al., 2007), and on reti-
noids, which encode a caudalizing activity
(Muhr et al., 1999; Liu et al., 2001;Maden,
2006). Similar to other bHLH transcrip-
tion factors (Bertrand et al., 2002; Imayo-
shi and Kageyama, 2014), Neurog3
appears tobe robustly expressed in commit-
ted p3 precursors but sharply downregu-
lated when converted into postmitotic V3
neurons.
Both gain- and loss-of-function exper-
iments in the chick and mouse embryo
demonstrate that Neurog3 regulates neu-
ronal fate choice in the p3 progenitor do-
main by translating regional signals along
the anterior–posterior axis into differen-
tial Ascl1 expression (Jacob et al., 2013).
Thus, by reducing Ascl1 levels in spinal p3
progenitors, Neurog3 excludes serotoner-
gic differentiation and allows V3 neuro-
genesis in the spinal cord (Fig. 8I). We
propose that the efficient downregulation
of Ascl1 and cell fate control by Neurog3
is, at least partially, a non-cell-autonomous
process (see Fig. 8I). This mechanism is
supported by the observations that Neu-
rog3 is not homogenously expressed in all
p3 cells, and that Hes5, a classical target of
Figure 7. Ectopic serotonergic specification in the spinal cord of Neurog3 mutants. A–D, Induction of 5-HT differentiation
program in the spinal cord ofNeurog3mutants. E11.5 or E12.5 spinal cord sectionswere hybridizedwith probes that recognize the
serotonergic-related transcription factors Ascl1 (A), Gata2 (B), Lmx1b (C), and Pet1 (D). In all cases a significantly increased
expression was found in the mutant spinal p3 domain. E–H, The heterotopic serotonergic specification in the spinal cord of
Neurog3 mutants requires Nkx2.2. Cross sections of E11.5 spinal cord from wild-type, Neurog3/, Nkx2.2/Neurog3, and Pax6/
Neurog3 double mutants were analyzed for Ascl1 (E), Gata2 (F ), Lmx1b (G), and Pet1 (H ) expression by in situ hybridization.
Quantitations of the signals are shown on the right. Pax6/;Neurog3/ embryos show a2-fold increase in ectopic differ-
entiation of 5-HT neurons in the spinal cord respect to Neurog3 single mutants. Bars are mean SD. Arrowheads point to p3
progenitors or postmitotic p3-derivedneurons. I–M, Heterotopic 5-HTneurons in theNeurog3/ spinal cord. Cross sections of
E12.5 (I, arrowhead) and P0 (J ) Neurog3/ andwild-type spinal cords were stained with an antibody against 5-HT. Arrows in I
point to cellular processes in the ventrolateral funiculus. K, Topological map of serotonergic neurons (n 98 cells) found in P0
4
Neurog3/ ventral spinal cord. L, M, Cross sections of P0
spinal cords showing an increased density of 5-HT fibers in
ventral funiculus (M) but not in lateral funiculus (L; see boxes
in K).N, O, Cross sections ofwild-type and Neurog3-null E12.5
spinal cordswerehybridizedwithprobes against the serotonin
transporter SerT (Slc6a4,N) and the vesicular glutamate trans-
porter vGluT3 (Slc17a8, O), which is also expressed in seroto-
nergic neurons. Arrowheads point to p3-derived neurons.
Scale bars: 50m.
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Notch signaling, is responsible for Ascl1 transcriptional repres-
sion in the p3 domain.
Our results show that in the absence of Neurog3, spinal p3 cells
produceserotonergicneurons.However, someV3interneuronsdodif-
ferentiate in theNeurog3/ spinal cord. This incomplete conver-
sion can be explained by Ascl1 not being equally de-repressed in
all spinal p3 cells (Fig. 5). It is possible that other caudalizing
signals (Jacob et al., 2013), still present inNeurog3mutants, nor-
mally operate togetherwithNeurog3 to achieve lowAscl1 expres-
sion and secure the exclusion of 5-HT neurons from the spinal
cord (Fig. 8I). Nevertheless it remains possible that the incom-
plete neuronal fate change reflects the existence of p3 cell sub-
populations or temporally coordinated neurogenic waves whose
specification programs are differentially affected by the loss of
Neurog3.
The results presented favor the notion that Neurog3 function
is to suppress Ascl1 expression and 5-HT neurogenesis in the
spinal cord, rather than instructing V3
differentiation. Actually, Neurog3 is not
strictly required for V3 interneuron spec-
ification, as someV3 interneurons are still
generated in Neurog3/ spinal cords
(Fig. 8A–F). The reduction observed in
V3 numbers in Neurog3 mutants can be
attributed to spinal p3 progenitors acquir-
ing a serotonergic fate (Fig. 5, 7). Never-
theless, we cannot rule out that Neurog3
may be additionally required to acquire a
complete V3 character including neu-
rotransmitter identity, since vGluT2 ex-
pression is more strongly affected by
Neurog3 loss compared with Sim1 and
Uncx (Fig. 8A–F).
In other systems, Neurog3 is a known
genetic switch that balances between
alternative cell fates from pluripotent
progenitors. In the pancreas Neurog3
specifies endocrine against exocrine fates
from multipotent pancreatic progenitors
(Gradwohl et al., 2000). In the hypothala-
mus, Neurog3 selects POMC at the ex-
pense of NPY and TH neurons (Pelling et
al., 2011). In contrast to these roles, our
experiments suggest a novel function for
Neurog3, in which it provides distinct re-
gional identities to spinal cord and hind-
brain p3 progenitors. In this context,
Neurog3, together with differential reti-
noid activity (Jacob et al., 2013), serves as
a mechanism for interpreting anterior–
posterior positioning to impose the cau-
dal border for the serotonergic system in
amniotes.
In themammalian central nervous sys-
tem serotonergic neurons are found ex-
clusively in the raphe nuclei. In contrast,
aquatic vertebrates, including the lam-
prey, fish, and amphibians, contain both
the brainstem raphe system and 5-HT
cells embedded in the spinal cord motor
networks (Harris-Warrick et al., 1985;
Branchereau et al., 2000; Lillesaar, 2011).
In the vertebrate spinal cord, 5-HT plays
an important role in organizing the locomotor pattern and can
profoundly modulate the motor output (Schmidt and Jordan,
2000). However, the functional significance of local intraspinal
serotonergic neurons is unclear, but might be related to phyloge-
netic locomotor modalities. In species lacking an intrinsic sero-
tonergic spinal system, such as mammals, these functions may
have been lost or may have been co-opted by raphe 5-HT de-
scending projections.Wehypothesize that the expression ofNeu-
rog3 in the embryonic spinal cord is important in this
evolutionary change. Supporting this proposal, studies in ze-
brafish have shown that Neurog3 is not expressed in the develop-
ing spinal cord (Wang et al., 2001). The absence of Neurog3
correlates with the production of Pet1-expressing 5-HT neu-
rons in the ventromedial spinal cord of zebrafish larvae (McLean
and Fetcho, 2004; Lillesaar et al., 2009).
In summary, our study demonstrates that spinal p3 progeni-
tors have the potential to produce serotonergic and V3 interneu-
Figure 8. Respecification of ventral neurons in Neurog3 mutant spinal cord. A–F, Serotonergic neurons in the Neurog3-null
spinal cord are produced at the expense of V3 interneurons. In situ hybridization of Sim1 (A), Uncx (B), and vGluT2 (Slc17a6, C) on
E11.5 spinal cord cross sections. Reduced expression was detected in Neurog3/ spinal cords compared with wild-type
littermates (D–F). Bars are mean SD; ***p 0.001, Mann–Whitney test. Arrowheads point to p3 progenitor cells or postmi-
totic neurons generated from this domain. G,H, Ectopic 5-HT neurons as well as a reduced V3 population arise from Neurog3/
p3domain, and segregate afterward.Wild-type andNeurog3/ spinal cord cross sectionswere hybridizedwithGata2, Sim1, and
Pet1 probes at E11.5 (G) and E12.5 (H). Signals fromadjacent sectionswere overlaid and pseudocolored. At E11.5 newborn ectopic
Gata2/Pet1-expressing cells and Sim1 neurons emanate both from p3 progenitors (G). By E12.5 each population occupies
different regions: Pet1 neurons are found adjacent to the ventrolateral funiculus while Sim1 neurons distribute throughout
the ventromedial spinal cord (H). Scale bars: 50m. I, Scheme of neuronal specification in the p3 domain of the hindbrain and
spinal cord, and the role of the transcription factor Neurog3 in restricting serotonergic neuron differentiation to the hindbrain.
Ventral signals (Shh) induce the expression of common transcriptional regulators in both thehindbrain and the spinal cord p3 early
progenitors. Caudalizing signals, such as RA, induce the onset of Neurog3 in p3 precursors of the spinal cord. Neurog3 represses
Ascl1 through a process mediated by Hes genes and thus prevents serotonergic specification in the spinal cord. Neurog3-
dependent downregulation of Ascl1 is likely to involve cell– cell interactions within the spinal p3 domain.
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rons, with the expression of Neurog3 being sufficient to suppress
the transcriptional program that supports 5-HTneuron develop-
ment. Neurog3 restricts serotonergic development to the hind-
brain and allows the production of a complete cohort of
glutamatergic V3 interneurons necessary to establish robust and bal-
anced spinal locomotor rhythms (Zhang et al., 2008; Borowska et al.,
2013).
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